Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV-002 with Carboplatin in Platinum-Resistant Ovarian Cancer
NCT00345540Phase 2Completed
- Sponsor
- Cellectar Biosciences
- Start
- Jul 2006
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glutathione disulfide in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Cellectar Biosciences. Started Jul 2006; status: completed.
02
Drugs
glutathione disulfide
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00345540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345540.